Financial Information
- Company Name
- AbbVie Inc.
- CIK Code
- 1551152
- SIC Code
- 2834
- Exchanges
- NYSE
- Tickers
- ABBV
| Date |
Revenue |
Operating Income |
Net Income |
Assets |
Liabilities |
Cash |
|---|
| Dec 22 |
$58,054,000,640 |
$18,116,999,168 |
$11,836,000,256 |
$138,805,002,240 |
$121,551,003,648 | $9,201,000,448 |
| Dec 21 |
$56,197,001,216 |
$17,923,999,744 |
$11,541,999,616 |
$146,528,993,280 |
$131,120,996,352 | $9,745,999,872 |
| Dec 20 |
$45,803,999,232 |
$11,363,000,320 |
$4,616,000,000 |
$150,564,995,072 |
$137,488,990,208 | $8,448,999,936 |
| Dec 19 |
$33,265,999,872 |
$12,983,000,064 |
$7,881,999,872 |
$89,115,000,832 |
$97,287,004,160 | $39,923,998,720 |
| Date | Equity | Retained Earnings | C. Assets | C. Liabilities | Dividends | Stock Outstanding |
|---|
| Dec 22 |
$17,254,000,640 | $4,784,000,000 | $28,462,999,552 | $29,538,000,896 | $10,042,999,808 | |
| Dec 21 |
$15,408,000,000 | $3,127,000,064 | $27,928,000,512 | $35,193,999,360 | $9,260,999,680 | |
| Dec 20 |
$13,075,999,744 | $1,055,000,000 | $24,173,000,704 | $28,661,000,192 | $7,715,999,744 | |
| Dec 19 |
$8,172,000,256 | $4,717,000,192 | $49,519,001,600 | $15,585,000,448 | $6,366,000,128 | |
Balance sheet values are in $USD. Not investment advice.
Recent ABBV Movement
-10.38% Loss between 2024-03-21 and 2024-05-02.